BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15201270)

  • 1. Reversible dilated cardiomyopathy associated with glucagonoma.
    Chang-Chretien K; Chew JT; Judge DP
    Heart; 2004 Jul; 90(7):e44. PubMed ID: 15201270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrolytic migratory erythema.
    Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
    J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid resolution of necrolytic migratory erythema after glucagonoma resection.
    Smith AP; Doolas A; Staren ED
    J Surg Oncol; 1996 Apr; 61(4):306-9. PubMed ID: 8628004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagonoma-associated dilated cardiomyopathy refractory to somatostatin analogue therapy.
    Barabas M; Huang-Doran I; Pitfield D; Philips H; Goonewardene M; Casey RT; Challis BG
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30836327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The question of surgical therapy for necrolytic migratory erythema, a cutaneous disease].
    Siegel R; Linse R; Rau B
    Chirurg; 2006 Jun; 77(6):535-8. PubMed ID: 16362349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of dilated cardiomyopathy after glucagonoma excision.
    Demir OM; Paschou SA; Ellis HC; Fitzpatrick M; Kalogeropoulos AS; Davies A; Thompson J; Davies SW; Grapsa J
    Hormones (Athens); 2015; 14(1):172-3. PubMed ID: 25553769
    [No Abstract]   [Full Text] [Related]  

  • 7. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
    Manes G; Pellegrini A; Riccardi F; Uomo G
    Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
    Kasper CS
    Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glucagonoma with diabetic ketoacidosis; case report].
    Lefebvre J; Lelièvre G; Dalle-Furnari MA; Proye C; Mazzuca M; Garraud JC; Luyckx A; Linquette M
    Diabete Metab; 1982 Sep; 8(3):191-5. PubMed ID: 6292011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in diagnosis and treatment of glucagonoma syndrome.
    Zhang M; Xu X; Shen Y; Hu ZH; Wu LM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):473-5. PubMed ID: 15313692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glucagonoma revealed by necrolytic migratory erythema].
    Bonaventure C; Merle P; Grezard P; Ruiz JM; Chevallier M; Scoazec JY; Trepo C
    Gastroenterol Clin Biol; 2003 Feb; 27(2):230-2. PubMed ID: 12658134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
    Chen HW; Chen HW; Su DH; Shun CT; Liu KL
    J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
    Toberer F; Hartschuh W; Wiedemeyer K
    Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Necrolytic migratory erythema as the first manifestation of glucagonoma].
    Chang CH; Sheu HM; Cheng GS; Yu HS
    J Formos Med Assoc; 1991 Dec; 90(12):1240-5. PubMed ID: 1686896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant glucagonoma of the pancreas diagnoses through anemia and diabetes mellitus.
    Koike N; Hatori T; Imaizumi T; Harada N; Fukuda A; Takasaki K; Iwamoto Y
    J Hepatobiliary Pancreat Surg; 2003; 10(1):101-5. PubMed ID: 12918465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Facial erythema and pancreatic glucagonoma].
    Erce C; Morales DJ; Diego L; Mazorra F; García de Polavieja M
    Rev Esp Enferm Dig; 1997 Feb; 89(2):137-8. PubMed ID: 9115822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.